Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients

• Published in: Modern rheumatology 2014-11, Vol.24 (6), p.945-948
• Main Authors: Kang, Eun Ha, Kuwana, Masataka, Okazaki, Yuka, Lee, Eun Young, Lee, Yun Jong, Lee, Eun Bong, Song, Yeong Wook
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; antibody specificities; Antigens; autoantibodies; Autoantibodies - analysis; Blotting, Western; Cancer; Comparative analysis; Dermatomyositis - diagnosis; Dermatomyositis - immunology; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoassay; Immunoglobulins; Male; Medical disorders; Middle Aged; myositis; Radioimmunoprecipitation Assay; Young Adult
• ISSN: 1439-7595; 1439-7609
• DOI: 10.3109/14397595.2014.896494

Abstract Background. To confirm the antigen specificities of autoantibodies that precipitate 140-kDa (anti-p140) or 155/140-kDa polypeptides (anti-p155/140) previously identified by radioimmunoprecipitation in Korean patients with dermatomyositis (DM) and to look into the relationship between each MSA and clinical features of DM. Methods. Seventeen serum samples of classic DM patients who had been found to have either anti-p140 antibodies (n = 9) or anti-p155/140 (n = 8) antibodies in our previous study were examined using enzyme-linked immunosorbent assay (for anti-MDA5 antibodies) and immunoblotting (for anti-MJ/NXP-2 and anti-TIF-1γ antibodies). Results. Seven out of nine anti-p140 antibody positive patients were found to have anti-MDA5 antibodies. Two out of nine had anti-MJ/NXP-2 antibodies with no interstitial lung disease (ILD). All eight anti-p155/140 antibody positive patients were found to have anti-TIF-1γ antibodies. Anti-TIF-1γ and anti-MDA5 antibodies were simultaneously detected in one patient with anti-p155/140 antibody, who suffered HIV infection and non-Hodgkin's lymphoma. The associations between anti-MDA5 antibody and rapidly progressive ILD and between anti-TIF-1γ antibody and cancer-associated DM were confirmed to be significant. Conclusions. Although radioimmunoprecipitation still looks to be a good screening tool, confirmation with antigen-specific assays seems mandatory. The associations between anti-MDA5 and rapidly progressive ILD and between anti-TIF-1γ and cancer-associated DM were confirmed in Korean patients with DM.